Skip to main content
Tuberculosis in Tondo, Manila - Ezra Acayan
Tuberculosis (TB) is one of the world’s biggest global health crises. Killing 1.3 million people in 2022, TB is the world’s second deadliest infectious disease after COVID-19.

Obsolete treatments, the lack of an effective vaccine, and the lack of suitable diagnostic tools make it difficult to control the global TB epidemic. In 2022, 7.5 million people across 192 countries and areas were diagnosed with TB.
 
Some gains have been made in recent years; the first new TB drugs in half a century and the trial of a shorter course of treatment for drug-resistant TB. But the harsh reality remains - 10.6 million people fell sick with TB and 410,000 developed multidrug-resistant TB (MDR-TB) in 2022, which is much harder to treat. Only about one-third of people with DR-TB accessed treatment in 2021. The majority go undiagnosed and therefore untreated.

Tuberculosis

Quick facts about tuberculosis

 
Nsanje: Treating advanced HIV
Access to medicines

MSF at the 48th Union World Conference on Lung Health

Event 10 Oct 2017
 
‘My doctors told me – this is the only chance’ - First Patient Finishes Treatment at MSF's TB Project in Belarus
Belarus

“My doctors told me it was my only chance”

Voices from the Field 15 Sep 2017
 
Destroyed Ambulances in East Ghouta, Syria
Global health

MSF urges G20 to take action on health issues

Press Release 6 Jul 2017
 
TB support in Swaziland
Eswatini

"A long and gruelling seven years and now it is over"

Voices from the Field 29 Jun 2017
 
Baby Nubia Is Released From MSF Clinic in Conakry
G20 Health Ministers’ Meeting

Open letter from MSF to the Meeting of the G20 Health Ministers

Open Letter 17 May 2017
 
Treating MDR-TB in Tajikistan, Dushanbe, Sept 2013
Tuberculosis

New report highlights need to better tackle world’s deadliest infectious disease

Project Update 7 May 2017
 
Sinethemba- MSF Treatment For TB in South Africa.
Tuberculosis

Fewer than five per cent of people in need are treated with new drugs

Press Release 23 Mar 2017
 
Georgia: DR-TB patients find hope in new treatments
Georgia

endTB partnership launches clinical trial to target toughest strains of tuberculosis

Statement 6 Mar 2017
 
Sign language training and TB support in Swaziland
Eswatini

For patients with XDR-TB, treatment is a gruelling journey with severe side effects

Voices from the Field 27 Feb 2017
fieldresearch.msf.org

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. Read all our Tuberculosis-related articles on our dedicated Field Research website.

View site
Osh project, fighting TB